Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

RM 581

Next Previous
Drug Profile

RM 581

Alternative Names: RM-581

Latest Information Update: 04 Jul 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CHU de Quebec Research Center-Universite Laval
  • Class Antineoplastics; Steroids
  • Mechanism of Action Endoplasmic reticulum stress stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Brain cancer; Colorectal cancer; Lung cancer; Pancreatic cancer; Prostate cancer

Most Recent Events

  • 03 Jul 2025 CHU de Quebec Research Center Universite Laval has patent pending for RM 581 in Canada(Neolyspharma pipeline, July 2025)
  • 03 Jul 2025 CHU de Quebec Research Center Universite Laval has patent protection for RM 581 in the US and Europe (Neolyspharma pipeline, July 2025)
  • 25 Apr 2025 Pharmacokinetics, adverse event data and pharmacodynamics data from preclinical trial in pancreatic cancer, Prostate cancer and breast cancer presented at the 116th Annual Meeting of the American Association for Cancer Research (AACR-2025)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top